Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Angelalign Technology's Other Operating Expense for the
six
months ended in Dec. 2025 was €-0.0 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €0.1 Mil.
Angelalign Technology's quarterly Other Operating Expense
increased
from Dec. 2024 (€0.0 Mil) to Jun. 2025 (€0.1 Mil) but then
declined
from Jun. 2025 (€0.1 Mil) to Dec. 2025 (€-0.0 Mil).
Angelalign Technology's annual Other Operating Expense
increased
from Dec. 2023 (€-2.0 Mil) to Dec. 2024 (€0.1 Mil) but then
declined
from Dec. 2024 (€0.1 Mil) to Dec. 2025 (€0.1 Mil).
Angelalign Technology Other Operating Expense Related Terms
Angelalign Technology Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Angelalign Technology's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Angelalign Technology Other Operating Expense Chart
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of €0.1 Mil mean?
Angelalign Technology (FRA:77D) has a Other Operating Expense of €0.1 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Angelalign Technology and its competitors.
Is Angelalign Technology's Other Operating Expense too high?
Angelalign Technology's current Other Operating Expense is €0.1 Mil. Overall, Angelalign Technology has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Angelalign Technology's Other Operating Expense compare to ISRG and BDX?
Angelalign Technology's Other Operating Expense of €0.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Angelalign Technology and its competitors. Angelalign Technology's current Other Operating Expense is €0.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angelalign Technology stock overvalued right now?
Based on GuruFocus' analysis, Angelalign Technology (FRA:77D) is currently considered Modestly Undervalued. The stock's GF Value™ is €11.73, compared to a current price of €8.65 — trading 26.3% below its estimated fair value. The current Other Operating Expense is €0.1 Mil. Angelalign Technology's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Angelalign Technology (FRA:77D), the current Other Operating Expense is €0.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Angelalign Technology (FRA:77D) Overvalued in 2026?
Based on GuruFocus' analysis, Angelalign Technology stock appears to be undervalued.
The current stock price of €8.65 is trading 26.3% below its estimated GF Value™ of €11.73.
GuruFocus considers Angelalign Technology to be Modestly Undervalued.
Key valuation signals for FRA:77D:
Other Operating Expense: €0.1 Mil
GF Value™: €11.73 vs. price of €8.65 (26.3% below fair value)
No single metric tells the full story. See the FRA:77D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions, including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontic solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review, and modify treatment plans.
75GF Score
Get the complete analysis for FRA:77D
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:77D has been successfully added to your 
